Controlled substances; regulate sale of nonpsychoactive consumable hemp products by Agriculture Department; require sale of products only in pharmacies; add psychoactive derivatives of hemp as Schedule I drug
What happened: This Alabama bill, referred to the Senate Healthcare Committee, would place regulation of nonpsychoactive hemp consumables under the Agriculture Department, restrict their sale to pharmacies only, and classify psychoactive hemp derivatives as Schedule I controlled substances.
Why it matters: Limiting hemp consumable sales to pharmacies would effectively exclude most current retailers from the market, while scheduling psychoactive hemp derivatives would expose cultivators, processors, and labs to controlled-substance compliance requirements.
Affects: retailers and cultivators and labs and patients
Legislative data via LegiScan, licensed under CC BY 4.0. Summaries and categorization by CannaSignal. Regulatory information, not legal advice.